177 related articles for article (PubMed ID: 29368979)
1. Beyond static measures: A review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophrenia.
Jelen LA; King S; Mullins PG; Stone JM
J Psychopharmacol; 2018 May; 32(5):497-508. PubMed ID: 29368979
[TBL] [Abstract][Full Text] [Related]
2. Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task.
Jelen LA; King S; Horne CM; Lythgoe DJ; Young AH; Stone JM
Eur Neuropsychopharmacol; 2019 Dec; 29(2):222-234. PubMed ID: 30558824
[TBL] [Abstract][Full Text] [Related]
3. Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Merritt K; Egerton A; Kempton MJ; Taylor MJ; McGuire PK
JAMA Psychiatry; 2016 Jul; 73(7):665-74. PubMed ID: 27304221
[TBL] [Abstract][Full Text] [Related]
4. Event-related dynamics of glutamate and BOLD effects measured using functional magnetic resonance spectroscopy (fMRS) at 3T in a repetition suppression paradigm.
Apšvalka D; Gadie A; Clemence M; Mullins PG
Neuroimage; 2015 Sep; 118():292-300. PubMed ID: 26072254
[TBL] [Abstract][Full Text] [Related]
5. Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.
Poels EM; Kegeles LS; Kantrowitz JT; Javitt DC; Lieberman JA; Abi-Dargham A; Girgis RR
Schizophr Res; 2014 Feb; 152(2-3):325-32. PubMed ID: 24418122
[TBL] [Abstract][Full Text] [Related]
6. Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study.
Iwata Y; Nakajima S; Plitman E; Caravaggio F; Kim J; Shah P; Mar W; Chavez S; De Luca V; Mimura M; Remington G; Gerretsen P; Graff-Guerrero A
Biol Psychiatry; 2019 Apr; 85(7):596-605. PubMed ID: 30389132
[TBL] [Abstract][Full Text] [Related]
7. Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.
Tarumi R; Tsugawa S; Noda Y; Plitman E; Honda S; Matsushita K; Chavez S; Sawada K; Wada M; Matsui M; Fujii S; Miyazaki T; Chakravarty MM; Uchida H; Remington G; Graff-Guerrero A; Mimura M; Nakajima S
Neuropsychopharmacology; 2020 Mar; 45(4):632-640. PubMed ID: 31842203
[TBL] [Abstract][Full Text] [Related]
8. Using proton magnetic resonance spectroscopic imaging to study glutamatergic alterations in patients with schizophrenia: A systematic review.
Plitman E; Guma E; Lepage M; Near J; Chakravarty MM
Schizophr Res; 2019 Aug; 210():13-20. PubMed ID: 31272905
[TBL] [Abstract][Full Text] [Related]
9. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
Moriguchi S; Takamiya A; Noda Y; Horita N; Wada M; Tsugawa S; Plitman E; Sano Y; Tarumi R; ElSalhy M; Katayama N; Ogyu K; Miyazaki T; Kishimoto T; Graff-Guerrero A; Meyer JH; Blumberger DM; Daskalakis ZJ; Mimura M; Nakajima S
Mol Psychiatry; 2019 Jul; 24(7):952-964. PubMed ID: 30315224
[TBL] [Abstract][Full Text] [Related]
10. Glutamate in dorsolateral prefrontal cortex and auditory verbal hallucinations in patients with schizophrenia: A
Ćurčić-Blake B; Bais L; Sibeijn-Kuiper A; Pijnenborg HM; Knegtering H; Liemburg E; Aleman A
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():132-139. PubMed ID: 28546056
[TBL] [Abstract][Full Text] [Related]
11. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of
Nakahara T; Tsugawa S; Noda Y; Ueno F; Honda S; Kinjo M; Segawa H; Hondo N; Mori Y; Watanabe H; Nakahara K; Yoshida K; Wada M; Tarumi R; Iwata Y; Plitman E; Moriguchi S; de la Fuente-Sandoval C; Uchida H; Mimura M; Graff-Guerrero A; Nakajima S
Mol Psychiatry; 2022 Jan; 27(1):744-757. PubMed ID: 34584230
[TBL] [Abstract][Full Text] [Related]
12. Effects of repeated dizocilpine treatment on glutamatergic activity in the prefrontal cortex in an animal model of schizophrenia: An in vivo proton magnetic resonance spectroscopy study at 9.4T.
Yoo CH; Song KH; Lim SI; Lee DW; Woo DC; Choe BY
Neurosci Lett; 2017 Jan; 637():57-63. PubMed ID: 27894920
[TBL] [Abstract][Full Text] [Related]
13. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
[TBL] [Abstract][Full Text] [Related]
14. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings.
Thakkar KN; Rösler L; Wijnen JP; Boer VO; Klomp DW; Cahn W; Kahn RS; Neggers SF
Biol Psychiatry; 2017 Mar; 81(6):525-535. PubMed ID: 27316853
[TBL] [Abstract][Full Text] [Related]
15. Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
Plitman E; Chavez S; Nakajima S; Iwata Y; Chung JK; Caravaggio F; Kim J; Alshehri Y; Chakravarty MM; De Luca V; Remington G; Gerretsen P; Graff-Guerrero A
Psychiatry Res Neuroimaging; 2018 Mar; 273():16-24. PubMed ID: 29414127
[TBL] [Abstract][Full Text] [Related]
16. Anterior Cingulate Cortex Glutamatergic Metabolites and Mood Stabilizers in Euthymic Bipolar I Disorder Patients: A Proton Magnetic Resonance Spectroscopy Study.
Soeiro-de-Souza MG; Otaduy MCG; Machado-Vieira R; Moreno RA; Nery FG; Leite C; Lafer B
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Dec; 3(12):985-991. PubMed ID: 29789269
[TBL] [Abstract][Full Text] [Related]
17. Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.
Barbagallo G; Arabia G; Novellino F; Nisticò R; Salsone M; Morelli M; Rocca F; Quattrone A; Caracciolo M; Sabatini U; Cherubini A; Quattrone A
Parkinsonism Relat Disord; 2018 Feb; 47():57-63. PubMed ID: 29203059
[TBL] [Abstract][Full Text] [Related]
18. Increased Glutamate concentrations during prolonged motor activation as measured using functional Magnetic Resonance Spectroscopy at 3T.
Volovyk O; Tal A
Neuroimage; 2020 Dec; 223():117338. PubMed ID: 32896636
[TBL] [Abstract][Full Text] [Related]
19. Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.
Merritt K; McCutcheon RA; Aleman A; Ashley S; Beck K; Block W; Bloemen OJN; Borgan F; Boules C; Bustillo JR; Capizzano AA; Coughlin JM; David A; de la Fuente-Sandoval C; Demjaha A; Dempster K; Do KQ; Du F; Falkai P; Galińska-Skok B; Gallinat J; Gasparovic C; Ginestet CE; Goto N; Graff-Guerrero A; Ho BC; Howes O; Jauhar S; Jeon P; Kato T; Kaufmann CA; Kegeles LS; Keshavan MS; Kim SY; King B; Kunugi H; Lauriello J; León-Ortiz P; Liemburg E; Mcilwain ME; Modinos G; Mouchlianitis E; Nakamura J; Nenadic I; Öngür D; Ota M; Palaniyappan L; Pantelis C; Patel T; Plitman E; Posporelis S; Purdon SE; Reichenbach JR; Renshaw PF; Reyes-Madrigal F; Russell BR; Sawa A; Schaefer M; Shungu DC; Smesny S; Stanley JA; Stone J; Szulc A; Taylor R; Thakkar KN; Théberge J; Tibbo PG; van Amelsvoort T; Walecki J; Williamson PC; Wood SJ; Xin L; Yamasue H; McGuire P; Egerton A;
Mol Psychiatry; 2023 May; 28(5):2039-2048. PubMed ID: 36806762
[TBL] [Abstract][Full Text] [Related]
20. Glutamate metabolites in treatment resistant schizophrenia: A meta-analysis and systematic review of
Kumar V; Manchegowda S; Jacob A; Rao NP
Psychiatry Res Neuroimaging; 2020 Jun; 300():111080. PubMed ID: 32279055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
